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ABSTRACT: The genetic engineering of microbial cell
factories is a sustainable alternative to the chemical synthesis
of organic compounds. Successful metabolic engineering often
depends on manipulating several enzymes, requiring multiple
transformation steps and selection markers, as well as protein
assembly and eﬃcient substrate channeling. Naturally
occurring fusion genes encoding two or more enzymatic
functions may oﬀer an opportunity to simplify the engineering
process and to generate ready-made protein modules, but their
functionality in heterologous systems remains to be tested. Here we show that heterologous expression of a fusion enzyme from
the marine alga Micromonas pusilla, comprising a mannitol-1-phosphate dehydrogenase and a mannitol-1-phosphatase, leads to
synthesis of mannitol by Escherichia coli and by the cyanobacterium Synechococcus sp. PCC 7002. Neither of the heterologous
systems naturally produce this sugar alcohol, which is widely used in food, pharmaceutical, medical, and chemical industries.
While the mannitol production rates obtained by single-gene manipulation were lower than those previously achieved after
pathway optimization with multiple genes, our ﬁndings show that naturally occurring fusion proteins can oﬀer simple building
blocks for the assembly and optimization of recombinant metabolic pathways.
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Microbial cell factories, particularly photosynthetic chassisthat consume carbon dioxide as their sole carbon source,
are an attractive alternative to chemical synthesis.1 They present
a sustainable approach to producing an array of substances with
usages in food, pharmaceutical, nutraceutical, and cosmetic
industries.
Biological production platforms struggle to compete
economically, particularly for the production of low value
commodity chemicals and materials.2 A recurring problem is
performance, which is measured as titer, yield, and productivity.
Artiﬁcial metabolic pathways inherently generate imbalances in
pathway ﬂux resulting in (toxic) intermediate and side product
accumulation, growth inhibition, and ultimately low product
yield.3 Therefore, individual modiﬁcations (e.g., the introduction
of a single enzyme or pathway) are not suﬃcient to achieve
industrially relevant titers. As a result, cell factory development
requires the introduction of several genes to synthesize the
desired product, the overproduction of precursors, and the
deletion of competing pathways.4,5
The use of fusion genes, generated from previously separate
genes, can help to simplify the biological engineering process.6
First, reducing the number of genes required for a synthetic
pathway simpliﬁes the design and assembly of synthetic
expression constructs as well as the transformation and selection
of producing strains. Second, reducing the number of enzymes
simpliﬁes assembly of protein complexes encoded by separate
genes and stoichiometric optimization to balance pathway ﬂux.
Furthermore, catalytic sites are brought in closer proximity, thus
enhancing substrate channeling and reducing intermediate
accumulation and/or loss to competing pathways.7 Additionally,
transit times for intermediate products between catalytic sites
are signiﬁcantly reduced, thus improving biosynthetic eﬃciency.
D-Mannitol is a sugar alcohol, or polyol, ubiquitous in
prokaryotes and eukaryotes, except for Archaea and animals. It
has desirable properties for food, pharmaceutical, medical, and
chemical industries.8 On the basis of a recent analysis of
mannitol market (http://www.grandviewresearch.com/
industry-analysis/mannitol-market), demand for this polyol,
driven by an increasing use in the food and pharmaceutical
sectors, is expected to reach 35.9 million kg representing a
market of USD 418.3 million by 2024.
Mannitol can be produced by extraction, chemical synthesis,
or biosynthesis. Traditionally, mannitol was harvested from
plant material that was seasonal and had highly variable yields.9
To stabilize mannitol supplies, commercial production now
mostly occurs through chemical hydrogenation of fructose-
glucose syrups. However, poor selectivity of the nickel catalyst
results in a mixture of mannitol and sorbitol that is relatively
diﬃcult to separate and thus costly.10 Chemical synthesis can be
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improved by altering the substrate, e.g., isomerizing glucose to
fructose by enzymatic conversion; however, enzyme availability
and added costs of additional steps prevent this from being
economical.
The chemical industry is now looking to biobased production
methods to reduce costs and environmental impact. The most
successful approach to mannitol biosynthesis currently uses
heterofermentative lactic acid bacteria. Under anaerobic
conditions, these organisms reduce fructose using the native
enzyme mannitol dehydrogenase. This approach requires an
external sugar supply that is (a) predominantly obtained from
traditional crops, e.g., corn, and (b) a major cost for biosynthesis
of commodities such as mannitol. External carbon sources and
associated costs can be eliminated from the bioproduction
pipeline by using photosynthetic organisms, which assimilate
atmospheric carbon dioxide into sugars via the Calvin cycle.11
Cyanobacteria represent an incredibly diverse phylum of
phototrophic prokaryotes that are being developed for photo-
synthetic bioproduction.12−14 One particularly attractive chassis
is the unicellular euryhaline cyanobacterium Synechococcus sp.
PCC 7002 due to its reported fast growth and tolerance of high
salt, light, and temperature.15−17 Importantly, Synechococcus is
amenable to natural transformation,18,19 and its genome is fully
sequenced (http://genome.microbedb.jp/cyanobase/
SYNPCC7002). Some molecular tools to engineer Synechococ-
cus have been developed including transformation vectors,
promoters to control transcription, and ribosome binding sites
to control translation.20−22
Synechococcus has previously been engineered to produce
mannitol from fructose-6-phosphate, an intermediate of the
Calvin cycle.23 This recombinant mannitol biosynthetic path-
way involved heterologous expression of two enzymes encoded
by separate genes: (1) an Escherichia coli gene encoding
mannitol-1-phosphate dehydrogenase (M1PDH), which cata-
lyzes the reduction of fructose-6-phosphate (F6P) to mannitol-
1-phosphate (M1P), and (2) an Eimeria tenella gene encoding
phosphohistidine mannitol-1-phosphatase (M1Pase), which
hydrolyses M1P to mannitol.
In recent years, new insights have been gained on the
mannitol biosynthetic pathway, notably in algae. The ﬁrst algal
genes involved in mannitol production were identiﬁed in the
model brown alga Ectocarpus,24 and biochemical character-
ization of the recombinant enzymes conﬁrmed M1PDH and
M1Pase function.25−27 Analysis of the distribution and
evolution of these mannitol biosynthetic genes across algal
lineages showed that mannitol synthesis is more widely spread
and diverse that initially thought.28 Interestingly, several fusion
genes combining modules for M1PDH and M1Pase activities
were identiﬁed, notably in marine green algae. For instance,
Mipuc10g00620 (http://bioinformatics.psb.ugent.be/orcae/
annotation/Mipuc/current/Mipuc10g00620) of Micromonas
pusilla strain CCMP1545 is predicted to encode an enzyme
expected to transform F6P directly into mannitol.
In this study, we explored whether the M1PDH/M1Pase
fusion gene of M. pusilla strain CCMP1545 is functional when
heterologously expressed in heterotrophic (E. coli) or photo-
autotrophic (Synechococcus) bacteria. To facilitate the engineer-
ing of Synechococcus we generated BioBrick-compatible
molecular tools (vectors and ribosome binding sites). We
found that both E. coli and Synechococcus produced mannitol
when transformed with the fusion gene. The one-step mannitol
production pathway provides an excellent starting point for
further optimization of sustainable mannitol production in
cyanobacteria.
■ RESULTS
Mpusfus Is Functional in E. coli. The M1PDH/M1Pase
fusion gene ofMicromonas pusilla strain CCMP1545 was codon
optimized for expression in Synechococcus (see Methods), and
we called the resulting sequencempusfus.To test expression and
function in heterologous systems, mpusfus was ﬁrst introduced
into E. coli using the pFO4 vector that carries an IPTG-inducible
expression system. A six-histidine tag was added to the 5′ end of
the gene. Western blot of protein extracts from IPTG-induced
cells revealed a band of the expected size, while no band was
detected in the controls without IPTG (Figure 1). The size of
the primary band was close to the value of 94.8 kDa calculated
for the full-length predicted amino acid sequence. This showed
that a single fusion protein was produced from the fusion gene.
Mannitol was measured both in the culture media and in the
cells after 20 h of incubation in absence and in the presence of
IPTG. In 5 mL cultures with a ﬁnal OD600 of 2.5−3.0 we found 1
± 0.05 mg of mannitol in the media and 0.08 ± 0.008 mg of
mannitol inside the cells (n = 3 clones) after incubation with
IPTG. Extrapolated to a 1 L culture, total mannitol production
was 218 ± 11.9 mg/L, of which 202 ± 10.7 mg (93%) were
exported into the medium and 16 ± 1.6 mg (7%) were retained
inside the cells. No mannitol was detected in cultures grown
without IPTG. The results showed that the algal fusion gene
produces a single protein in E. coli that catalyzes the biosynthesis
of mannitol.
New Molecular Tools and Protocols To Engineer
Synechococcus sp. PCC 7002. BioBricks represent the largest
collection of standardized parts for genetic engineering.29 While
a number of genetic tools have been developed for
Synechococcus,20−22 none of them are compatible with BioBrick
parts. In order to develop a BioBrick-compatible integration
vector for Synechococcus, we reengineered an existing expression
vector, pAQ1EX.30 This vector targets the transgene to a neutral
site in the native, high copy pAQ1 plasmid of Synechococcus.
Figure 1. Expression of the M1PDH/M1Pase fusion protein in E. coli.
Western blot analysis of His-tagged M1PDH/M1Pase in soluble
fractions of protein extracts from E. coli transformed with mpusfus.
Lanes marked 1, 2, and 3 contain protein extracts from three
independent clones after culture in absence (−) and in presence (+)
of IPTG.Numbers at the left of the panel indicate size (kDa) of proteins
in the ladder.
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BioBrick preﬁx and suﬃx sequences containing the restriction
enzyme recognition sites required for gene assembly were
synthesized and inserted into the integrative region of the
pAQ1EX vector. For ease of cloning, domestication of DNA
parts is important, whereby BioBrick restriction sites do not
occur outside of the preﬁx and suﬃx sequences. An XbaI site
occurring directly upstream of the selective aadA gene was
therefore replaced with an XhoI site. Finally, the phycocyanin
promoter of Synechocystis sp. PCC 6803, PcpcB594, which has been
reported to be a strong promoter in cyanobacteria, was inserted
into the BioBrick cloning site.31 The resulting vector called
pAQ1BB provides a convenient tool for transformation of
Synechococcus sp. PCC 7002 (Figure 2). The target integration
site (“landing pad”) can be modiﬁed by replacing homologous
sequences Flank A and Flank B using NsiI/EcoRI and SalI/SphI
restriction sites, respectively. The marker gene for selection can
be modiﬁed using XhoI and SalI restriction sites.
Using established protocols for natural transformation,30
transformation eﬃciency of Synechococcus with pAQ1BB was
initially poor. Increasing both the amount of DNA and
incubation time prior to plating onto selective media
signiﬁcantly enhanced transformation eﬃciency (Figure S1).
The optimized transformation protocol can be found in the
Methods section.
Ribosome binding sites (RBSs) play an essential role in
translation initiation during protein synthesis. Software have
been developed to design synthetic RBSs considering factors
such as secondary mRNA structure inﬂuenced by ﬂanking
nucleotide sequences, the Shine−Dalgarno (SD) sequence
complementary to the 16S rRNA, spacing between the SD and
start codon, and the sequence of the start codon itself.32 We used
a web-based RBS calculator33 to design RBS for Synechococcus
(sequences in Table S2) and assessed the suitability of three
potential RBS for producing green ﬂuorescent protein (GFP).
RBS-GFP were cloned into pAQ1BB and used to transform
Synechococcus. Similar to a previous report,21 we observed a
moderate correlation between predicted and actual translation
rates (Figure 3). Both the RBS calculator and the GFP-assay
identiﬁed RBS3 as the strongest RBS, and we therefore used
RBS3 to express mpusfus.
To assess promoter activity in combination with RBS3, we
monitored GFP ﬂuorescence in the PcpcB594:RBS3-GFP
expressing cells over the course of culture growth. The
experiment showed that the promoter is most active in the
early exponential phase (Figure 4) as previously suggested.30
Mpusfus Is Functional in Synechococcus sp. PCC 7002.
Synechococcus was transformed with the plasmid containing
PcpcB594:RBS3-mpusfus. Initial growth rates were slightly
impaired in the engineered Synechococcus and the densities of
stationary phase cultures were slightly lower than in wild type
cells (Figure 5A). Mannitol was measured in the media and in
the cell pellet of wild type- and mpusfus-expressing cultures. No
mannitol was detected in wild type cultures, conﬁrming a
Figure 2. New BioBrick vector for transformation of Synechococcus sp.
PCC 7002. Region between Flanks A and B stably integrates into the
native pAQ1 plasmid of Synechococcus by homologous recombination.
This region includes a spectinomycin resistance gene (aadA) and the
BioBrick cloning site containing the phycocyanin promoter of
Synechocystis sp. PCC 6803 (PcpcB594).
Figure 3. Predicted and measured strength of synthetic ribosome
binding sites for Synechococcus sp. PCC 7002. Gray bars represent
translation initiation rates predicted in silico using RBS calculator. Black
bars represent GFP ﬂuorescence normalized to cell density (optical
density at 730 nm, OD730). Each RBS-GFP construct was expressed in
Synechococcus under the control of the PcpcB594 promoter and GFP
ﬂuorescence was measured when culture density reached anOD730 of 1.
Data are presented as means ± SEM of three independent cultures.
BBa_0030 is a standard RBS from the Registry of Standardised Parts.
RBS1, RBS2, and RBS3 were forward engineered using RBS calculator.
Figure 4. Promoter activity over the course of culture growth. Black
points represent culture density (OD730). Gray points represent GFP
ﬂuorescence normalized to cell density (GFP/OD730). RBS3-GFP was
expressed in Synechococcus under the control of the PcpcB594 promoter
and GFP ﬂuorescence was measured over the course of culture growth.
Data are presented as means ± SEM of three independent cultures.
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previous report that Synechococcus does not naturally produce
mannitol.23 By contrast, mannitol was detected both in the
cellular fraction and in the media ofmpusfus-expressing cultures,
indicating that the fusion protein is functional in Synechococcus.
Total mannitol steadily increased over the course of culture
growth to around 100 mg/L in early stationary phase (Figure
5A). Mannitol in the cellular fraction of the culture increased
with culture growth (Figure 5B), but the majority of mannitol
produced was exported into the medium. At the end of the
experiment over 99% of the total mannitol was found in the
culture medium.
Mannitol production rates were calculated by dividing the
amount of mannitol produced between two time points by time
and by mean cell number (OD730) in this time period. As shown
in Figure 5C the production rate increased to 7 μg/day/OD on
day 28 (mid-exponential phase) and then decreased.
In summary, the results show that expression of a single fusion
gene encoding two enzyme functions results in the production of
mannitol in heterologous systems that do not naturally
synthesize mannitol.
■ DISCUSSION
Use of Fusion Genes for Biotechnology. Fusion genes
encode more than one enzymatic function in one gene. They
have potential beneﬁts for biotechnology because they would
reduce the number of constructs and transformations required
for engineering metabolic pathways. Furthermore, it is hoped
that, in a naturally evolved fusion protein, occurrence of adjacent
modules catalyzing consecutive steps in a metabolic process will
prevent loss of intermediate through eﬃcient substrate
channeling. However, functionality of fusion genes/proteins in
heterologous systems remained to be proven. In this study, we
show that a fusion gene from the green algaMicromonas pusilla is
functional and suﬃcient to achieve production of mannitol in
prokaryotic systems, namely E. coli and Synechococcus sp. PCC
7002.
M. pusilla strain CCMP1545 is a unicellular marine green alga
that is a potentially valuable source of fusion genes for
biotechnology. A high quality draft of its 22 Mb genome is
available, and resolution continues to improve around the
telomeric regions of its 19 chromosomes.34,35 Bioinformatic
analyses have identiﬁed a number of fusion genes in the
CCMP1545 genome encoding enzymes involved in a variety of
cellular processes including pigment production,36 polyamine
biosynthesis,37 DNA double-strand break repair38 and carbon
ﬁxation.35 Some Micromonas genes have been characterized by
heterologous expression to date,39−42 but none of them encode
fusion proteins. Therefore, the potential of the Micromonas
fusion genes for metabolic engineering remained to be explored.
The gene employed in this study combined a M1PDH and an
M1Pase module and was tested for producing mannitol in
prokaryotic model systems.
We ﬁrst expressed the mpusfus fusion gene in E. coli. This
organism has been previously engineered to develop whole-cell
biotransformation systems for mannitol synthesis from
glucose,43,44 resulting in mannitol molar yield of 80%43 and
87%.44 We found that E. coli expressing the singlempusfus fusion
gene produced a single recombinant protein of approximately
100 kDa and produced mannitol, most of which was exported
into themedium. This shows that the fusion protein is functional
in E. coli. However, the achieved mannitol concentration of 218
mg/L under our experimental conditions (molar yield of 2% on
glucose) was considerably lower than in the previously
engineered strains.43,44 Additional manipulations addressing
codon usage, metabolic ﬂux toward substrate, substrate
transport, and feeding could now be attempted to increase
mannitol titers in E. coli.
Photosynthetic bacteria provide an opportunity to produce
organic compounds from CO2 without the need of feeding
sugars. We were therefore interested to test whether thempusfus
fusion gene can be used to produce mannitol in a photo-
autotrophic system. Synechococcus sp. PCC 7002 is one of the
model systems for metabolic engineering of cyanobacteria and
has previously been engineered to produce mannitol from F6P
using two separate genes (M1PDH from E. coli and M1Pase
from Eimeria tenella).23 As E. coli, Synechococcus does not possess
an endogenous pathway for mannitol production. To facilitate
the engineering of Synechococcus, we ﬁrst generated a BioBrick
compatible vector and a synthetic ribosomal binding site. The
new tools in combination with a previously identiﬁed “super-
strong” promoter were conﬁrmed by GFP-assay and are
available to the scientiﬁc community.
Figure 5. Mannitol production in mpusfus-expressing Synechococcus
cultures. (A) Line graphs represent culture growth as optical density at
730 nm (OD730) measured over time in wild type (black symbols) and
engineered Synechococcus (gray triangles) expressingmpusfus under the
control of PcpcB594 and RBS3. Gray bars represent total mannitol (sum
of mannitol measured in the cellular fraction and in the medium). (B)
Amount of mannitol (per 1 L culture) present in the cellular fraction of
the engineered Synechococcus culture. (C) Mannitol production rate in
the engineered Synechococcus culture normalized to OD730. All data are
means ± SEM of three independent cultures.
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Successful functional expression of mpusfus in Synechococcus
was proven by the appearance of mannitol in the transgenic
cultures. As before,23 the majority of mannitol produced was
exported into the media where it can easily be harvested. Since
Synechococcus does not naturally produce mannitol it is likely
that the export occurs through nonspeciﬁc transport proteins for
other compounds. Synechococcus and other cyanobacteria have
been shown to release low-molecular-weight metabolites when
subjected to hypo-osmotic stress,45,46 but the exact transport
pathways remain to be identiﬁed.
The total amount of mannitol produced in this report is
considerably lower than in the previous study,23 namely around
0.1 g/L compared to 0.6 g/L. Usage of a glycogen-deﬁcient
strain helped to increase titers,23 but the main diﬀerences
between the two studies lies in the growth rate of the cultures.
The highest mannitol-producing strain reported previously23
reached a maximal OD730 of around 10 within 150 h and
achieved the aforementioned mannitol concentration in 300 h.
By contrast, our strain grew much more slowly and required 50
days to produce 0.1 g/L mannitol albeit reaching a higher OD730
of 25. It is likely that protein turnover over such a long period of
time prevents the accumulation and maintenance of substantial
amounts of recombinant protein. Protein synthesis then
becomes very sensitive to promoter activity, which was maximal
during early culture growth (see Figure 4). A combination of low
promoter activity and protein turnover would explain why
production rates were very low and decreased even before the
cultures entered stationary phase (see Figure 5C). It can
therefore be expected that usage of new promoter(s), which are
active during the late stages of growth, and changes in growth
conditions, e.g., fed-batch cultivation to keep cultures in the
production stage for longer, could increase mannitol productiv-
ity by engineered Synechococcus sp. PCC 7002.
Despite the ability of cyanobacteria to use atmospheric carbon
for industrial bioproduction, carbon availability is a key limiting
factor in polyol production. The use of fast-growing strains and
the development of eﬃcient photobioreactors will be crucial to
move toward industrial scale production systems that can
compete with the traditional sugar-fed cultures. Our demon-
stration that an algal fusion gene is functional in cyanobacteria
presents an important step toward simplifying the generation of
recombinant metabolic pathways, and can now be combined
with the usual metabolic engineering strategies to overcome
metabolic bottlenecks. Metabolic network models have become
available for Synechococcus,47 which should facilitate this task.
■ METHODS
Construction of pAQ1BB Vector for Transformation of
Synechococcus sp. PCC 7002. The integrative vector
pAQ1EX for transformation of Synechococcus sp. PCC 700230
was modiﬁed to accommodate BioBrick assembly. Synthetic
oligonucleotides were annealed to generate BioBrick preﬁx and
suﬃx sequences ﬂanked by restriction site overhangs for
insertion into pAQ1EX using EcoRI/NcoI and NdeI/BamHI
restriction sites respectively (Table S1). To prevent interference
with the BioBrick assembly, an XbaI restriction site at the 5′ end
of the spectinomycin resistance gene aadA was replaced with an
XhoI restriction site by site-directed mutagenesis using primers
listed in Table S1. Modiﬁcations were conﬁrmed by sequencing,
and the resulting vector was designated pAQ1BB. To drive
transgene expression, the 594 bp phycocyanin promoter of
Synechocystis sp. PCC 6803, PcpcB594
30 was ampliﬁed by PCR
from genomic DNA using forward primer 5′-GAATTC-
GCGGCCGCTTCTAGAGTTCGTTATAAAATAAACTTA-
ACAAATCTATAC-3′ and reverse primer 5′-CTGCAG-
CGGCCGCTACTAGTAGGAATTAATCTCCTACTTGAC-
TTTATG-3′, and inserted into the pAQ1BB BioBrick cloning
site.
Generation of Codon-Optimized mpusfus. The 863 aa
M1PDH/M1Pase fusion protein of Micromonas pusilla strain
CCMP1545 contains codons that may reduce translation
eﬃciency in cyanobacteria. Codon optimization for expression
in Synechococcus sp. PCC 7002 was therefore performed
(GenScript USA Inc.) using the OptimumGene algorithm,
which takes into consideration a variety of parameters important
for gene expression eﬃciency. These include, but are not limited
to, codon usage bias, GC content, mRNA secondary structure,
internal ribosome binding sites, and restriction sites. Codon
usage bias is scored as a codon adaptation index (CAI), where
CAI 1.0 is optimal in the desired expression organism, andCAI >
0.8 is regarded as good in terms of high expression. Following
codon optimization, the CAI was improved from 0.66 in the
native gene to 0.96 in the codon-optimized gene (Supporting
Information and Figure S1). GC content and distribution was
also optimized to prolong the half-life of the mRNA, and stem-
loop secondary structures were broken to improve mRNA
stability and ribosomal binding. Five internal ribosome binding
sites were removed to prevent any aberrant translation from
within the coding sequence. Finally, six restriction sites involved
in BioBrick assembly were removed. The resulting codon-
optimized gene was designated mpusfus. Details of codon
optimization, native and optimized sequences can be found in
the Supporting Information.
Generation of Transgenic Synechococcus sp. PCC 7002
Strains. Synthetic ribosome binding sites were designed using
RBS calculator33 and added directly upstream of the transgene
during PCR ampliﬁcation (primer sequences can be found in
Table S2). Following sequence conﬁrmation in the pGEM-T
Easy vector (Promega, UK ), the ampliﬁed DNA (RBS + gene)
was cloned into the pAQ1BB vector, downstream of the PcpcB594
promoter. The synthetic expression constructs were integrated
into the Synechococcus genome by natural transformation.
Transformation eﬃciency was optimized by varying either
amount of DNA (1−25 μg) or incubation time (1−3 days) prior
to plating on selective media (Figure S1), and the following
optimized transformation protocol was used: 1.5 mL culture
(OD730 1) was combined with 10 μg circular plasmid DNA and
incubated for 72 h under standard growth conditions with
minimal sparging. Cells were plated on solid A+ medium with
1.5% w/v agar and 50 μg/mL spectinomycin. Single colonies
appeared after 5−7 days. Individual colonies were isolated and
grown for characterization. Genomic DNA was isolated using
phenol-chloroform extraction,48 and the correct insertion of the
synthetic expression constructs were veriﬁed by PCR
ampliﬁcation using primers pAQ1BB-seq-F (5′-CACAT-
GAGAATTTGTCCAG-3′) and pAQ1BB-seq-R (5′-CCTTT-
CGGGCTTTGTTAG-3′) and sequencing.
Synechococcus sp. PCC 7002 Growth. Synechococcus sp.
PCC 7002 cultures were grown in A+ medium18 (containing
300 mM NaCl) at 30 °C with photoperiod 16 h/8 h light/dark,
light intensity 150 μmol photons m−2 s−1 and sparged with
humidiﬁed ambient air (standard conditions). Cultures of
transformed Synechococcus were supplemented with 25 μg/mL
spectinomycin. For mannitol analyses, cultures were grown to
OD730 1−3, diluted to OD730 1 and 1.3 mL was inoculated to
400 mL A+ medium. At regular intervals throughout culture
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growth, OD730 was measured and 20 mL of culture were
harvested by centrifugation at 4000g for 15 min. Supernatants
were transferred to fresh tubes and stored at −20 °C. Cells were
resuspended in 3 mL fresh Medium A+, transferred to a fresh 15
mL Falcon tube, centrifuged at 4000g for 15 min at 4 °C,
supernatants were discarded and pellets were frozen at −20 °C.
For subsequent analysis, cells were freeze-dried overnight at−50
°C and 0.13 mbar, and resuspended in 1 mL of Tris-HCl 10 mM
pH 8.0. After ﬁve freeze−thaw cycles, cell suspensions were
sonicated (5 × 30 s) using an ultrasonic processor VC50
sonicator (Jencons), and cell debris pelleted by centrifugation 15
min at 12 500g. Aliquots of the cell lysates were used for
determination of intracellular mannitol concentration.
Generation of Transgenic E. coli Strain. Mpusfus DNA
without the initial start codon was ampliﬁed from the plasmid
carrying the codon-optimized gene with the forward primer 5′-
GGGGGGGGATCCAATAGTGCCGTGACCATCAGCC-3′
(BamHI restriction site underlined) and the reverse primer 5′-
CCCCCCGAATTCTTAGCGGGGATTGGGATCTTC-3′
(EcoRI restriction site underlined). The PCR fragment obtained
was cloned into the vector pFO4 as previously described,49
producing the plasmid pMPUSFUS and allowing the recombi-
nant proteins to be fused to a six-histidine tag at their N-
terminus. This plasmid was subsequently transformed in E. coli
expression strain BL21 (DE3). For gene induction and
functional assays, three distinct recombinant clones were
precultured in 5 mL of M9 medium supplemented with 10 g/
L of glucose and 0.1 g/L ampicillin overnight at 37 °C and 200
rpm. The following day, new cultures were started at OD600 0.1
under the same conditions. When OD600 0.5 was attained,
cultures were divided into two tubes, and isopropyl β-D-1-
thiogalactopyranoside (IPTG) was added in one of them at a
ﬁnal concentration of 1 mM. Incubation was carried out for 20 h
at 25 °C and 200 rpm, and cultures reached a ﬁnal OD600 of 2.5−
3.0 in both induced and noninduced conditions. Samples were
then harvested by centrifugation at 3500g for 10 min.
Supernatants and cell pellets were frozen individually at −20
°C for downstream analyses. To determine intracellular
mannitol concentration, cells were resuspended in 600 μL of
buﬀer Tris-HCl 25 mM pH 7.5 and NaCl 200 mM, and
disrupted by four pulses of 15 s of sonication using an ultrasonic
processor VC50 sonicator (Jencons). Cell debris were pelleted
by centrifugation at 14 000g and 4 °C for 20 min; supernatants
were used for mannitol analysis and considered as soluble
fractions for protein gel andWestern-blot analysis. Proteins were
quantiﬁed using the Pierce Coomassie Plus Assay Kit (Thermo
Fisher Scientiﬁc) according to manufacturer's instructions.
Three μg of protein of each fractions were loaded on a 10%
Mini-PROTEAN TGX Precast Protein Gels (Biorad). After
separation, proteins were transferred to nitrocellulose mem-
brane using the iBlot 2 Dry blotting System (Thermo Fisher
Scientiﬁc). Recombinant proteins were visualized with a
conjugated monoclonal anti-polyhistidine-peroxidase antibody
(Sigma-Aldrich) detected by the SuperSignal West Pico
Chemiluminescent Substrate (Thermo Fisher Scientiﬁc).
Measurement of GFP. RBS and promoter activity was
assessed in transgenic cyanobacteria using a GFP reporter
encoded by BioBrick part BBa_E0040. Cultures were harvested
for GFP measurements at the same point during the diurnal
cycle and, when appropriate, growth stage. Optical density was
adjusted toOD730 0.25−0.30 in fresh A+media and ﬂuorescence
was measured using a LS 55 Luminescence Spectrophotometer
(PerkinElmer, UK) using 480 nm excitation and 514 nm
emission wavelengths.
Mannitol Analysis. To determine mannitol production,
50−200 μL aliquots of culture media or bacterial extracts were
analyzed with the D-Mannitol/L-Arabitol assay kit (K-MANOL,
Megazyme) according to the manufacturer’s instructions.
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